0 0 0 0 0 0 0 0
Sign Up Today X
Thanks for submitting the form.
Stockreport

Corbus Pharmaceuticals: Downgrade To Hold Due To Narrow Focus Window [Seeking Alpha]

Corbus Pharmaceuticals Holdings, Inc. (CRBP)  More Company Research Source: Seeking Alpha
Last corbus pharmaceuticals holdings, inc. earnings: 3/12 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: corbuspharma.com
CRBP will now focus on unmet needs in 2nd-line head and neck squamous cell carcinoma and cervical cancer, where early data shows superior ORRs. The company has a solid cash runway through Q2 2027 and upcoming catalysts, including an FDA meeting in H2 2025 and potential phase 3 trial initiations in 2026. Risks for CRBP include competitive pressures for both CRB-701 and CRB-601, as well as the need to replicate early efficacy and safety in larger trials. Moment Makers Group/iStock via Getty Images The last time I spoke about Corbus Pharmaceuticals Holdings, Inc. CRBP ), it was in a Seeking Alpha article entitled "Corbus: Nectin-4 Targeting Proven With U.S. Data On The Way Early 2025." At that time, I More on my IG service This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period fo [Read more]
IMPACT SNAPSHOT EVENT TIME: CRBP
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
CRBP alerts
from News Quantified
CRBP
NEWS
CRBP
Earnings
CRBP
Analyst Actions
CRBP
SEC Filings
Stockreport

Corbus Pharmaceuticals: Downgrade To Hold Due To Narrow Focus Window [Seeking Alpha]

Corbus Pharmaceuticals Holdings, Inc.  (CRBP) 
More Company Research Source: Seeking Alpha
Last corbus pharmaceuticals holdings, inc. earnings: 3/12 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: corbuspharma.com
CRBP will now focus on unmet needs in 2nd-line head and neck squamous cell carcinoma and cervical cancer, where early data shows superior ORRs. The company has a solid cash runway through Q2 2027 and upcoming catalysts, including an FDA meeting in H2 2025 and potential phase 3 trial initiations in 2026. Risks for CRBP include competitive pressures for both CRB-701 and CRB-601, as well as the need to replicate early efficacy and safety in larger trials. Moment Makers Group/iStock via Getty Images The last time I spoke about Corbus Pharmaceuticals Holdings, Inc. CRBP ), it was in a Seeking Alpha article entitled "Corbus: Nectin-4 Targeting Proven With U.S. Data On The Way Early 2025." At that time, I More on my IG service This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period fo [Read more]
IMPACT SNAPSHOT
EVENT TIME:
CRBP
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS